Targeted News Service

FDA Unveils Draft Guidance for Obesity and Overweight Drug Development
January 08, 2025

WASHINGTON, Jan. 8 (TNSFR) -- The U.S. Food and Drug Administration (FDA) has announced the availability of a new draft guidance for the development of drugs and biological products aimed at weight reduction for individuals with obesity or those classified as overweight with related medical conditions.

This draft guidance, titled "Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction," revises a previous version from 2007, reflecting the cu . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form